Skip to main content
AIRS
NASDAQ Industrial Applications And Services

AirSculpt Posts Q2 Loss, Slashes EBITDA Outlook, and Restructures Debt

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$4.35
Mkt Cap
$353.434M
52W Low
$1.51
52W High
$12
52W Position info
188% above low
Off High info
64% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

AIRS has more than doubled off its 52-week low of $1.51.

Summary

A Q2 loss, a slashed full-year EBITDA outlook, and a debt amendment requiring $5 million in near-term payments were disclosed, while the company continued to tap its ATM program for cash.


Key Events · Earnings and Guidance · AIRS

  • Q2 Loss and Revenue Decline

    Revenue fell 3% to $42.9 million, resulting in a net loss of $1.1 million ($0.02 per share), compared with a $0.6 million loss a year ago. Same-center case volume grew 1%, but revenue per case dropped 2%.

  • Full-Year EBITDA Guidance Cut

    Management reaffirmed revenue at the lower end of $151–$157 million but reduced adjusted EBITDA guidance to $12–$14 million, down from prior expectations, reflecting higher costs and margin compression.

  • ATM Dilution Continues

    An additional $5.0 million was raised from the at-the-market offering program during Q2, adding to the $14.8 million raised earlier in 2026. Weighted average shares outstanding jumped to 70.8 million from 59.6 million a year ago.

  • Debt Amendment Requires Near-Term Payments

    On August 7, 2026, the term loan was amended, extending maturity to November 2027 but requiring a $2.5 million payment at signing and another $2.5 million by September 30, 2026. The amendment also mandates that 50% of future equity issuance proceeds be used to prepay debt.


Analysis · AIRS · Industrial Applications And Services

A Q2 net loss of $1.1 million on revenue of $42.9 million underscores mounting pressure, as same-center case volume edged up 1% but revenue per case declined. While the lower end of full-year revenue guidance was reaffirmed, the adjusted EBITDA forecast was cut sharply to $12–$14 million, signaling deepening margin compression. Concurrently, the company raised $5 million from its ATM program and amended its term loan, extending maturity to November 2027 but requiring $5 million in near-term principal payments. The combination of weak earnings, reduced guidance, and ongoing dilution from the ATM program raises concerns about cash burn and shareholder value.

At the time of this filing, AIRS was trading at $4.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $353.4M. The 52-week trading range was $1.51 to $12.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AIRS - Latest Insights

AIRS
Aug 10, 2026, 6:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $4.81
Real-time Price: $3.54 info
Change: -$1.27 (-26%) info
Market Cap: $353.434M info
AIRS
May 13, 2026, 6:24 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.18
Real-time Price: $3.54 info
Change: -$0.640 (-15%) info
Market Cap: $353.434M info
AIRS
May 08, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.83
Real-time Price: $3.54 info
Change: -$0.2878 (-8%) info
Market Cap: $353.434M info
AIRS
May 08, 2026, 6:35 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.56
Real-time Price: $3.54 info
Change: -$0.020 (-0.56%) info
Market Cap: $353.434M info
AIRS
May 08, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $3.56
Real-time Price: $3.54 info
Change: -$0.020 (-0.56%) info
Market Cap: $353.434M info